Cargando…
A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma
BACKGROUND: To evaluate the impact of treatment on health states that affect patients’ quality of life in advanced follicular lymphoma. METHODS: A quality-adjusted time without symptoms of disease or toxicity of treatment (Q-TwiST) analysis was performed on data from a phase III clinical trial (Marc...
Autores principales: | Marcus, R, Aultman, R, Jost, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813752/ https://www.ncbi.nlm.nih.gov/pubmed/19920818 http://dx.doi.org/10.1038/sj.bjc.6605443 |
Ejemplares similares
-
Abnormal CVP waveform
por: Raut, Monish S., et al.
Publicado: (2013) -
“x” descent of CVP: An indirect measure of RV dysfunction ?
por: Raut, Monish S., et al.
Publicado: (2014) -
Cardiac output and CVP monitoring… to guide fluid removal
por: Legrand, Matthieu, et al.
Publicado: (2018) -
IJV collapsibility index vs IVC collapsibility index by point of care ultrasound for estimation of CVP: a comparative study with direct estimation of CVP
por: Jassim, Haitham Mohammed, et al.
Publicado: (2019) -
CVP does not reflect changes in preload when optimal PEEP is determined
por: Tóth, I, et al.
Publicado: (2005)